Phillippe Sourdille says 'Merci' to ASCRS after being recognized as Honoured Guest

Arthur Cummings
Published: Saturday, April 18, 2015
Lauded for pioneering intraocular lens implants in Europe, his outstanding research in preventing PCO and post-surgical inflammation, and pivotal roles founding the ESCRS and the Journal of Cataract and Refractive Surgery, Phillippe Sourdille MD, Nantes, France, was recognized as an Honoured Guest at the 2015 American Academy of Cataract and Refractive Surgery Symposium.
Addressing the opening session, Dr Sourdille acknowledge the challenge of moving forward with new technology such as femtosecond lasers, and its potential impact on surgical skills and practice. But he warned against going backward, and encouraged ophthalmologists everywhere to work together to further improve eye care and surgery. “We know the answer is international exchange and teamwork.”
On receiving the honour from incoming ASCRS President Robert J Cionn, Dr Sourdille said: “I can summarize my thoughts in one single French word, and this word is ‘Merci.’
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.